Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Sclerouvectomy plus intraoperative ophthalmic brachytherapy for iris-ciliary body melanomas.

Tytuł:
Sclerouvectomy plus intraoperative ophthalmic brachytherapy for iris-ciliary body melanomas.
Autorzy:
Relimpio-López MI; Retina Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; Ocular Oncology Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; RETICS OftaRed, Institute of Health Carlos III, Madrid, Spain.
Garrido-Hermosilla AM; Oculoplastics-Orbit Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; Ocular Oncology Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; RETICS OftaRed, Institute of Health Carlos III, Madrid, Spain. Electronic address: .
Espejo-Arjona F; Retina Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; Ocular Oncology Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; RETICS OftaRed, Institute of Health Carlos III, Madrid, Spain.
Coca-Gutiérrez LM; Retina Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; Ocular Oncology Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain.
Díaz-Granda MJ; Retina Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; Ocular Oncology Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; RETICS OftaRed, Institute of Health Carlos III, Madrid, Spain.
Rodríguez-de-la-Rúa-Franch E; Retina Unit, Department of Ophthalmology, Virgen Macarena University Hospital, Seville, Spain; RETICS OftaRed, Institute of Health Carlos III, Madrid, Spain.
Źródło:
Surgical oncology [Surg Oncol] 2021 Mar; Vol. 36, pp. 113-114. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji:
Case Reports; Journal Article
Język:
English
Imprint Name(s):
Publication: Amsterdam : Elsevier Science
Original Publication: Oxford ; Boston : Blackwell Scientific Publications, c1992-
MeSH Terms:
Brachytherapy/*methods
Ciliary Body/*radiation effects
Ciliary Body/*surgery
Iris/*radiation effects
Iris/*surgery
Melanoma/*therapy
Sclera/*surgery
Uveal Neoplasms/*therapy
Ciliary Body/pathology ; Combined Modality Therapy ; Humans ; Intraoperative Care ; Iris/pathology ; Melanoma/pathology ; Prognosis ; Uveal Neoplasms/pathology ; Video Recording
Contributed Indexing:
Keywords: Intraoperative ophthalmic brachytherapy; Iris-ciliary body melanoma; Sclerouvectomy
SCR Disease Name:
Uveal melanoma
Entry Date(s):
Date Created: 20201219 Date Completed: 20211019 Latest Revision: 20211019
Update Code:
20240105
DOI:
10.1016/j.suronc.2020.11.020
PMID:
33340808
Czasopismo naukowe
Background: Partial lamellar sclerouvectomy was designed more than 30 years ago by Jerry and Carol Shields, in order to remove melanomas that involved the ciliary body and/or the choroid, while leaving intact the outer portion of the sclera and the overlying sensory retina [1].
Methods: We present two cases of iris-ciliary body melanoma with different size. The performed surgery was a partial lamellar sclerouvectomy plus iridectomy, complemented by intraoperative juxtalimbar ruthenium-106 brachytherapy.
Results: Both cases achieved anatomical success without developing chronic ocular hypotony in the postoperative period, an infrequent but possible complication [2]. Even one of them reached a best-corrected visual acuity of 0.7 after silicone oil removal and intravitreal implant of dexamethasone because of secondary macular edema. The other remains stable with counting fingers vision. In this case, the poor functional outcome might be influenced by larger size and longer evolution of the tumor, as well as the uncontrolled arterial hypertension and older age of the patient.
Discussion: Intraoperative ophthalmic brachytherapy may have a beneficial effect not only over neoplastic activity [2], but also over early choroidal detachments. Its pro-fibrotic/hemostatic stimulus should be further examined by comparative studies with larger cohorts, either prospectively or retrospectively. Other protective factors could be the utilization of equine pericardial grafts for covering scleral defects as well as leaving high-density silicone oil. Another key aspect is to maintain low blood pressure levels during these procedures in order to avoid intraocular hemorrhages [3], especially when the patient exceeds the sixth decade, so the anaesthesiologist will also play a decisive role in the operating room. We prefer to anticipate the likely development of lens opacification after this operation [4], performing cataract surgery at the beginning and using a Cionni capsular tension ring due to a probable zonular instability. Pars plana vitrectomy would also remove peripheral vitreoretinal tractions and seal the retina preventing a detachment.
Conclusion: As can be observed during the surgical video, a wide range of complications could occur during a partial lamellar sclerouvectomy. Tackle them ahead of time is crucial to achieve anatomical and functional success.
(Copyright © 2020 Elsevier Ltd. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies